ArticleAmerican journal of preventive cardiology2026
Circulating multiple metals and mortality after myocardial infarction: incremental value beyond GRACE.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metals such as arsenic, cadmium, and lead have been increasingly recognized as emerging cardiovascular risk factors, yet it is not considered in current clinical risk stratification for patients after myocardial infarction (MI). Methods: This prospective study consecutively enrolled 1,283 post-MI patients undergoing percutaneous coronary intervention between 2017 and 2021, with follow-up through April 2024. Baseline plasma levels of 19 metals were measured by inductively coupled plasma mass spectrometry. Associations between metals and all-cause mortality were evaluated using multivariable Cox proportional hazards models. Models were adjusted for age, sex, body mass index, smoking status, diabetes, hypertension, hyperlipidemia, estimated glomerular filtration rate, peak troponin I, prior PCI, and stent implantation. To assess joint associations of multiple metals, we fitted elastic net regularized Cox models and derived environmental metal risk scores (ERSs), which were added to the GRACE risk score to assess incremental prognostic value via C-statistics, time-dependent receiver operating characteristic curves, and reclassification metrics. Results: Among 1,283 patients, 122 all-cause mortality occurred during a median follow-up of 4.28 years. Higher plasma concentrations of copper, lead, and strontium were significantly associated with increased risks of all-cause mortality. Fully adjusted hazard ratios with 95% confidence intervals (per 1-standard deviation increase in log-transformed concentrations) were 1.67 (1.34-2.07) for copper, 1.26 (1.06-1.50) for lead, and 1.43 (1.20-1.71) for strontium. Higher ERS was also positively associated with all-cause mortality. Incorporation of ERS into the GRACE score improved discrimination at 5 years, increasing the area under the curve from 0.77 to 0.81 ( Conclusions: Plasma copper, lead, and strontium levels were associated with all-cause mortality after MI, and further validation in independent cohorts is warranted before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.